Directory
>
Ray Shiao
Ray Shiao
Executive Director, FP&A | Entrada Therapeutics
Cambridge, Massachusetts, United States
Ray Shiao
Summary
Ray Shiao is a seasoned finance professional with over 20 years of experience specializing in financial planning and analysis within the pharmaceutical and high-tech industries. Currently serving as the Executive Director of FP&A at Entrada Therapeutics, he has a proven track record of leading cross-functional teams and implementing business process improvements. Ray is adept at managing financial systems and data warehouses, and he excels in creating complex financial reports that support executive decision-making. His expertise encompasses financial modeling, forecasting, and compliance with regulations such as Sarbanes-Oxley. Ray holds an MBA from Boston College and a B.S. in Finance from Santa Clara University. He is passionate about leveraging financial insights to drive strategic initiatives and enhance organizational efficiency. Outside of work, Ray is committed to continuous learning and staying updated on industry trends.
Ray Shiao
Work Experience
Executive Director, FP&A at
Entrada Therapeutics
April 2023 - Present
Senior Director, FP&A at
Evelo Biosciences
July 2021 - April 2023
Director, FP&A at
Evelo Biosciences
October 2019 - June 2021
Associate Director of Finance at
Sunovion Pharmaceuticals
January 2019 - October 2019
Sr. Manager, FPA at
Sunovion Pharmaceuticals
January 2016 - January 2019
Manager, FP&A at
Sunovion Pharmaceuticals
January 2014 - January 2016
Principal Financial Analyst at
Sunovion Pharmaceuticals
October 2010 - January 2014
Financial Consultant/Area Business Manager at
Oracle
May 2008 - October 2010
Financial Manager at
Oracle
November 2006 - April 2008
Senior Financial Analyst at
Oracle
May 2004 - November 2006
Financial Systems Analyst at
Oracle
July 2001 - May 2004
Database Coordinator at
Oracle
July 1998 - July 2001
Ray Shiao
Education
Boston College Carroll School of Management, Mba
January 2004 - January 2008
Santa Clara University, B.S. Finance
January 1996 - January 2000
Frequently Asked Questions about Ray Shiao
What is Ray Shiao email address?
Ray Shiao's primary email address is ******@entradatx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Ray Shiao work for?
Ray Shiao is a Executive Director, FP&A at Entrada Therapeutics, a company specializing in Commercial physical research.
Where Ray Shiao graduated from?
Ray Shiao holds a degree in General Mba from Boston College Carroll School of Management.
How can I directly contact Ray Shiao?
To contact Ray Shiao directly, you can use the email address ******@entradatx.com. Complete contact information is available upon registration with Muraena.
Who is Ray Shiao?
Ray Shiao is a seasoned finance professional with over 20 years of experience specializing in financial planning and analysis within the pharmaceutical and high-tech industries. Currently serving as the Executive Director of FP&A at Entrada Therapeutics, he has a proven track record of leading cross-functional teams and implementing business process improvements. Ray is adept at managing financial systems and data warehouses, and he excels in creating complex financial reports that support executive decision-making. His expertise encompasses financial modeling, forecasting, and compliance with regulations such as Sarbanes-Oxley. Ray holds an MBA from Boston College and a B.S. in Finance from Santa Clara University. He is passionate about leveraging financial insights to drive strategic initiatives and enhance organizational efficiency. Outside of work, Ray is committed to continuous learning and staying updated on industry trends.
Ray`s contact details
******@entradatx.com
Colleagues
Vice President
Executive Director
Vice President, Head of Cardiovascular and Neuromuscular & Cardiovascular Therapeutics
Chief Financial Officer and Treasurer
Board Member
Co-Founder & Vice President, Discovery Research
Vice President | Head of CMC
President Research And Development at Entrada Therapeutics
President and Chief Operating Officer
VP, Program Governance & Portfolio Management